Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
'Ecstasy' Slated for Phase 3 Trials
The U.S. Food and Drug Administration (FDA) has given the go-ahead to Phase 3 clinical trials of MDMA, also known as Ecstasy, the drug notorious for causing injury and death to users at music festivals and dance clubs. The approval to conduct the trials came after promising Phase 2 trial results showed patients with post-traumatic stress disorder (PTSD) experienced a marked decrease in symptoms after just three doses of psychiatrist-ordered MDMA. Further, the majority of those taking part in that trial — primarily military veterans, rape victims and police and fire department personnel who suffered PTSD because of their experiences — no longer fit the diagnostic criteria for PTSD once the trial was finished. The Multidisciplinary Association for Psychedelic Studies, which conducted the Phase 2 trials, will also conduct the Phase 3 trials.
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN ENTERTAINMENT LAW.
Already a have an account? Sign In Now Log In Now
For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473
Defining commercial real estate asset class is essentially a property explaining how it identifies — not necessarily what its original intention was or what others think it ought to be. This article discusses, from a general issue-spot and contextual analysis perspective, how lawyers ought to think about specialized leasing formats and the regulatory backdrops that may inform what the documentation needs to contain for compliance purposes.
As courts and discovery experts debate whether hyperlinked content should be treated the same as traditional attachments, legal practitioners are grappling with the technical and legal complexities of collecting, analyzing and reviewing these documents in real-world cases.
How to Convey Your Merits In a Way That Earns Trust, Clients and Distinctions Just as no two individuals have the exact same face, no two lawyers practice in their respective fields or serve clients in the exact same way. Think of this as a "Unique Value Proposition." Internal consideration about what you uniquely bring to your clients, colleagues, firm and industry can provide untold benefits for your law practice.
The ever-evolving digital marketing landscape, coupled with the industry-wide adoption of programmatic advertising, poses a significant threat to the effectiveness and integrity of digital advertising campaigns. This article explores various risks to digital advertising from pixel stuffing and ad stacking to domain spoofing and bots. It will also explore what should be done to ensure ad fraud protection and improve effectiveness.
This article offers practical insights and best practices to navigate the path from roadmap to rainmaking, ensuring your business development efforts are not just sporadic bursts of activity, but an integrated part of your daily success.